Lagging demand for the iPhone X and reports from smartphone chipmakers of decreased orders has some analysts predicting that Apple will retire its most expensive phone.
Mirabaud analyst [Neil Campling](https://www.cnbc.com/2018/04/20/apple-iphone-x-discontinued-this-year-analyst-says.html) said he anticipates the iPhone X will likely be discontinued this year.
According to Sascha Segan, lead analyst for PCMag.com, that's not going to happen. Instead, Segan said that Apple would launch new iPhones in the fall and the X would live on as the premium iPhone on the market.
"We are going to do a little flipping here," said Segan. "You have this prestige position where the X is, and then the 11 and then the 12 possibly."
When asked if the X is worthy of that prestige position, Segan said, "No, I never thought the iPhone X was worth a thousand dollars."
The iPhone X is still the most profitable iPhone despite underwhelming demand. Segan said that Apple was testing consumers' limits with the iPhone X. But he thinks the company will keep pushing those limits.
For full interview, [click here](https://cheddar.com/videos/iphone-x-dead).
Ben Geman, Energy Reporter at Axios, joins to discuss the latest Middle East tensions, Brent crude price swings, and why gas prices aren’t falling with oil.
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
